A Systematic Review and Meta-Analysis Examining the Risk of Adverse Pregnancy and Neonatal Outcomes in Women with Isolated Hypothyroxinemia in Pregnancy
Thyroid® · 2023-05 · 33 (5) · 603-614
DOI: 10.1089/thy.2022.0600 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Thyroid®, online erschienen am 04.05.2023. Verfasst von Yutong Han und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, NHC Key Laboratory of Diagnosis and Treatment of Thyroid Diseases, Institute of Endocrinology; and Shenya…. Hauptthemen laut MEDLINE: Premature Birth, Diabetes, Gestational. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 50 Literaturangaben.
Abstract (Originalsprache)
Background
The relationship between isolated hypothyroxinemia (IH) in pregnancy and adverse pregnancy outcomes is controversial, with no consensus on the need for treatment. Summary: We conducted a systematic review and meta-analysis examining adverse pregnancy and neonatal outcomes in women with IH in pregnancy. We searched PubMed, Embase, Web of Science, and the Cochrane Central Register of Controlled Trials for publications from inception to December 2022. Randomized clinical trials and cohort studies were included. Random-effects meta-analyses were used to estimate pooled relative risks (RRs) for each outcome. We included 21 articles, of which 19 investigated the relationship between IH and maternal and neonatal outcomes and 4 investigated the efficacy of levothyroxine (LT4) treatment. Compared with euthyroid pregnancies, IH pregnancies were associated with an increased risk of preterm birth (RR 1.35 [confidence interval, CI, 1.16–1.56]; I 2 = 9%), premature rupture of membranes (RR 1.41 [CI 1.08–1.84]; I 2 = 0%), gestational diabetes (RR 1.34 [CI 1.07–1.67]; I 2 = 76%), macrosomia (RR 1.62 [CI 1.31–2.02]; I 2 = 42%), and fetal distress (RR 1.72 [CI 1.15–2.56]; I 2 = 0%). However, no statistically significant differences were noted in adverse outcomes according to LT4 treatment status.
Conclusions
There is evidence suggesting that IH in pregnancy may be associated with an increased risk of adverse pregnancy and neonatal outcomes. However, it is unclear whether LT4 may mitigate the risk of these adverse outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology and Metabolism, NHC Key Laboratory of Diagnosis and Treatment of Thyroid Diseases, Institute of Endocrinology; and Shenyang, China.
- Department of General Practice; The First Affiliated Hospital of China Medical University, Shenyang, China.
- Department of Endocrinology, Peking University Third Hospital, Beijing, China.
ORCID-Profile: Xiaotong Gao, Xichang Wang, Chenyu Zhang
Zitieren
APA
Han, Y., Gao, X., Wang, X., Zhang, C., Gong, B., Peng, B., Li, J., Liu, A., & Shan, Z. (2023). A Systematic Review and Meta-Analysis Examining the Risk of Adverse Pregnancy and Neonatal Outcomes in Women with Isolated Hypothyroxinemia in Pregnancy. Thyroid®, 33(5), 603-614. https://doi.org/10.1089/thy.2022.0600
Vancouver
Han Y, Gao X, Wang X, Zhang C, Gong B, Peng B, et al. A Systematic Review and Meta-Analysis Examining the Risk of Adverse Pregnancy and Neonatal Outcomes in Women with Isolated Hypothyroxinemia in Pregnancy. Thyroid®. 2023;33(5):603-614. doi:10.1089/thy.2022.0600
BibTeX
@article{Han2023,
author = {Han, Yutong and Gao, Xiaotong and Wang, Xichang and Zhang, Chenyu and Gong, Boshen and Peng, Bingcong and Li, Jiashu and Liu, Aihua and Shan, Zhongyan},
title = {A Systematic Review and Meta-Analysis Examining the Risk of Adverse Pregnancy and Neonatal Outcomes in Women with Isolated Hypothyroxinemia in Pregnancy},
journal = {Thyroid®},
year = {2023},
volume = {33},
number = {5},
pages = {603--614},
doi = {10.1089/thy.2022.0600}
}
EUVIMED